Biopharmaceutical Contract Manufacturing Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Global Biopharmaceutical Contract Manufacturing Market is Segmented by Product Type (Peptides/Proteins, Antibodies, Vaccines, Biosimilars, and Other Product Types) and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers the market size and forecasts in terms of value in USD million for the above segments.

Biopharmaceutical Contract Manufacturing Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Biopharmaceutical Contract Manufacturing Industry Overview

The biopharmaceuticals contract manufacturing market is consolidated and consists of a few major players. In terms of market share, certain major players are currently dominating the market. Some of the companies currently dominating the market are Boehringer Ingelheim GmbH, Lonza, Inno Biologics Sdn Bhd, Rentschler Biotechnologies GmbH, JRS Pharma (Celonic), Samsung BioLogics, WuXi Biologics, AGC Biologics, ProBioGen AG, and FUJIFILM Diosynth Biotechnologies USA Inc.

Biopharmaceutical Contract Manufacturing Market Leaders

  1. Boehringer Ingelheim GmbH

  2. JRS Pharma (Celonic)

  3. Lonza Group

  4. Rentschler Biotechnologie GmbH

  5. Inno Biologics Sdn Bhd

  6. *Disclaimer: Major Players sorted in no particular order
Biopharmaceuticals Contract Manufacturing Market Concentration

Biopharmaceutical Contract Manufacturing Market Report Snapshots

80% of our clients seek made-to-order reports. How do you want us to tailor yours?